Allergan to pay $2.7m to settle antitrust suit over Asacol

06-08-2019

Saman Javed

Allergan to pay $2.7m to settle antitrust suit over Asacol

casimiropt / Shutterstock.com

A subsidiary of Irish pharmaceutical company Allergan is to pay a combined total of $2.7 million to three organisations that were part of an antitrust class against the drugmaker.


Allergan, US District Court for the District of Massachusetts,Minnesota Laborers Health and Welfare Fund, Asacol, generics, antitrust

More on this story

Actavis and Zydus settle Asacol patent dispute
10-06-2014

LSIPR